chr16-67939933-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000229.2(LCAT):​c.1294G>A​(p.Ala432Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 31)

Consequence

LCAT
NM_000229.2 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.509
Variant links:
Genes affected
LCAT (HGNC:6522): (lecithin-cholesterol acyltransferase) This gene encodes the extracellular cholesterol esterifying enzyme, lecithin-cholesterol acyltransferase. The esterification of cholesterol is required for cholesterol transport. Mutations in this gene have been found to cause fish-eye disease as well as LCAT deficiency. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.21895167).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LCATNM_000229.2 linkc.1294G>A p.Ala432Thr missense_variant Exon 6 of 6 ENST00000264005.10 NP_000220.1 P04180A0A140VK24

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LCATENST00000264005.10 linkc.1294G>A p.Ala432Thr missense_variant Exon 6 of 6 1 NM_000229.2 ENSP00000264005.5 P04180
LCATENST00000570369.5 linkc.296G>A p.Cys99Tyr missense_variant Exon 3 of 3 2 ENSP00000459014.1 I3L1Q6
LCATENST00000573538.5 linkn.*615G>A non_coding_transcript_exon_variant Exon 5 of 5 3 ENSP00000463220.1 J3QKT0
LCATENST00000573538.5 linkn.*615G>A 3_prime_UTR_variant Exon 5 of 5 3 ENSP00000463220.1 J3QKT0

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
Oct 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 432 of the LCAT protein (p.Ala432Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with LCAT-related conditions. ClinVar contains an entry for this variant (Variation ID: 1714636). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Not Available". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:1
Nov 17, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.A432T variant (also known as c.1294G>A), located in coding exon 6 of the LCAT gene, results from a G to A substitution at nucleotide position 1294. The alanine at codon 432 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Uncertain
0.094
D
BayesDel_noAF
Benign
-0.10
CADD
Benign
9.3
DANN
Benign
0.95
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.30
FATHMM_MKL
Benign
0.43
N
LIST_S2
Benign
0.48
T
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.22
T
MetaSVM
Uncertain
0.13
D
MutationAssessor
Benign
1.3
L
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.29
N
REVEL
Benign
0.28
Sift
Benign
0.12
T
Sift4G
Benign
1.0
T
Polyphen
0.73
P
Vest4
0.15
MutPred
0.16
Gain of glycosylation at A432 (P = 0.0021);
MVP
0.90
MPC
0.39
ClinPred
0.21
T
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr16-67973836; API